BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19304912)

  • 1. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone.
    Dasgupta C; Sakurai R; Wang Y; Guo P; Ambalavanan N; Torday JS; Rehan VK
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L1031-41. PubMed ID: 19304912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury.
    Rehan VK; Sakurai R; Corral J; Krebs M; Ibe B; Ihida-Stansbury K; Torday JS
    Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L672-80. PubMed ID: 20729387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo.
    Rehan VK; Wang Y; Patel S; Santos J; Torday JS
    Pediatr Pulmonol; 2006 Jun; 41(6):558-69. PubMed ID: 16617452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-β signaling.
    Sakurai R; Li Y; Torday JS; Rehan VK
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L721-30. PubMed ID: 21821729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts.
    Sakurai R; Cerny LM; Torday JS; Rehan VK
    Exp Lung Res; 2011 Apr; 37(3):144-54. PubMed ID: 21133803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of nicotine-induced alveolar lipofibroblast-to-myofibroblast transdifferentiation by stimulants of parathyroid hormone-related protein signaling.
    Rehan VK; Sakurai R; Wang Y; Santos J; Huynh K; Torday JS
    Lung; 2007; 185(3):151-9. PubMed ID: 17401602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of pioglitazone, a PPARγ agonist, and synthetic surfactant B-YL prevents hyperoxia-induced lung injury in adult mice lung explants.
    Kurihara C; Sakurai R; Chuang TD; Waring AJ; Walther FJ; Rehan VK
    Pulm Pharmacol Ther; 2023 Jun; 80():102209. PubMed ID: 36907545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
    Nicola T; Ambalavanan N; Zhang W; James ML; Rehan V; Halloran B; Olave N; Bulger A; Oparil S; Chen YF
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul; 301(1):L125-34. PubMed ID: 21531777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia.
    Alejandre-Alcázar MA; Kwapiszewska G; Reiss I; Amarie OV; Marsh LM; Sevilla-Pérez J; Wygrecka M; Eul B; Köbrich S; Hesse M; Schermuly RT; Seeger W; Eickelberg O; Morty RE
    Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L537-49. PubMed ID: 17071723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin protects the developing lung against long-term hyperoxic injury.
    Sakurai R; Villarreal P; Husain S; Liu J; Sakurai T; Tou E; Torday JS; Rehan VK
    Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L301-11. PubMed ID: 23812632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized PPARγ agonists: a novel approach to augment neonatal lung maturation and injury repair in rats.
    Morales E; Sakurai R; Husain S; Paek D; Gong M; Ibe B; Li Y; Husain M; Torday JS; Rehan VK
    Pediatr Res; 2014 May; 75(5):631-40. PubMed ID: 24488089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia.
    Lee HJ; Lee YJ; Choi CW; Lee JA; Kim EK; Kim HS; Kim BI; Choi JH
    Yonsei Med J; 2014 Jan; 55(1):99-106. PubMed ID: 24339293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Combination of the Aerosolized PPAR-γ Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats.
    Sakurai R; Lee C; Shen H; Waring AJ; Walther FJ; Rehan VK
    Neonatology; 2018; 113(4):296-304. PubMed ID: 29428947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.
    Zhou B; Buckley ST; Patel V; Liu Y; Luo J; Krishnaveni MS; Ivan M; DeMaio L; Kim KJ; Ehrhardt C; Crandall ED; Borok Z
    PLoS One; 2012; 7(6):e38827. PubMed ID: 22745681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Am J Pathol; 2017 Aug; 187(8):1660-1669. PubMed ID: 28606794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of LRP5/6-mediated Wnt/β-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats.
    Alapati D; Rong M; Chen S; Lin C; Li Y; Wu S
    Pediatr Res; 2013 Jun; 73(6):719-25. PubMed ID: 23481549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of rosiglitazone against hyperoxia-induced lung injury in neonatal rats].
    Cai Q; Xu MY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Apr; 14(4):301-5. PubMed ID: 22537963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.
    Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B
    J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia.
    Rath P; Nardiello C; Surate Solaligue DE; Agius R; Mižíková I; Hühn S; Mayer K; Vadász I; Herold S; Runkel F; Seeger W; Morty RE
    Pediatr Res; 2017 May; 81(5):795-805. PubMed ID: 28141790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia.
    Alapati D; Rong M; Chen S; Hehre D; Hummler SC; Wu S
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):104-13. PubMed ID: 24484510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.